| Dec'17 | Dec'16 | Dec'15 | Dec'14 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-23,205 | -25,869 | - | - | |||
Net loss | ||||||
- | - | -24,971 | -19,040 | |||
Adjustments required to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation | ||||||
940 | 833 | 583 | 233 | |||
Depreciation | ||||||
794 | 620 | 339 | 204 | |||
Impairment of property and equipment | ||||||
388 | 0 | 380 | 0 | |||
Accrued severance pay, net | ||||||
- | - | 3 | 13 | |||
Amortization of discount on loan | ||||||
- | - | 11 | 12 | |||
Re-evaluation of fair value of warrants to purchase Convertible Preferred Shares | ||||||
- | - | -40 | - | |||
Re-evaluation of fair value of warrants to purchase Ordinary Shares | ||||||
2,448 | -2,491 | - | 2,927 | |||
Issuance costs related to warrants to purchase Ordinary Shares | ||||||
441 | 784 | - | - | |||
Decrease (increase) in other accounts receivable and prepaid expenses | ||||||
340 | -136 | 138 | -291 | |||
Decrease in deferred revenues | ||||||
-1,065 | -1,065 | 2,131 | - | |||
Increase (decrease) in trade payables | ||||||
-1,545 | 1,010 | -467 | 1,190 | |||
Increase (decrease) in other accounts payable and accrued expenses | ||||||
-1,098 | 192 | 590 | 799 | |||
Net cash used in operating activities | ||||||
-22,242 | -25,850 | - | - | |||
Cash flows from investing activities: | ||||||
Net cash used in operating activities | ||||||
- | - | -21,579 | -13,371 | |||
Proceeds from maturity of investments in restricted cash | ||||||
- | 308 | 703 | 703 | |||
Purchase of property and equipment | ||||||
1,710 | 2,384 | 1,880 | 948 | |||
Decrease (increase) in long-term deposit | ||||||
49 | -61 | -15 | - | |||
Net cash used in investing activities | ||||||
-1,661 | -2,137 | - | - | |||
Cash flows from financing activities: | ||||||
Net cash used in investing activities | ||||||
- | - | -1,192 | -245 | |||
Repayment of loan | ||||||
- | 234 | 563 | 563 | |||
Proceeds from warrants exercised | ||||||
4,866 | - | - | - | |||
Proceeds from options exercised | ||||||
165 | - | 145 | 1 | |||
Proceeds from issuance of Convertible Preferred Shares and warrants, net of issuance costs | ||||||
- | - | 11,406 | 19,206 | |||
Deferred IPO costs | ||||||
- | - | - | 933 | |||
Proceeds from issuance of Ordinary Shares, net of issuance costs upon IPO | ||||||
- | - | 36,159 | - | |||
Proceeds from issuance of Ordinary Shares, net of underwriters' fees | ||||||
- | - | 1,308 | - | |||
Proceeds from issuance of Ordinary Shares and warrants, net of issuance costs | ||||||
28,110 | 19,585 | - | - | |||
Net cash provided by financing activities | ||||||
33,141 | 19,351 | - | - | |||
Net increase (decrease) in cash and cash equivalents | ||||||
9,238 | -8,636 | - | - | |||
Net cash provided by financing activities | ||||||
- | - | 48,455 | 17,711 | |||
Net increase (decrease) in cash and cash equivalents | ||||||
- | - | 25,684 | 4,095 | |||
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Purchase of property and equipment | ||||||
231 | 201 | 48 | - | |||
Exercise of warrants into Ordinary Shares | ||||||
5,177 | - | - | - | |||
Conversion of Convertible Preferred Shares into Ordinary Shares | ||||||
- | - | 47,075 | - | |||
Conversion of warrants to purchase Convertible Preferred Shares into Ordinary Shares | ||||||
- | - | 5,945 | - | |||
Non-cash deferred IPO costs | ||||||
- | - | 933 | 529 | |||
Conversion of Warrants to purchase Convertible Preferred Shares into Warrants to purchase Ordinary Shares | ||||||
- | - | 87 | - | |||
Cash paid during the period: | ||||||
Cash paid for taxes and interest | ||||||
212 | 449 | - | - | |||
Cash paid for interest | ||||||
- | - | 30 | 60 | |||
Cash paid for taxes | ||||||
- | - | 325 | - | |||